These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2136939)

  • 1. The effect of ramipril, a new angiotensin-converting enzyme inhibitor on cortical nephron flow and effective renal plasma flow in patients with essential hypertension.
    al-Nahhas AM; Nimmon CC; Britton KE; Carroll MJ; al-Janabi MA; Solanki K; Bomanji J
    Nephron; 1990; 54(1):47-52. PubMed ID: 2136939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measurement of intrarenal plasma flow distribution in essential hypertension. The effect of angiotensin-converting enzyme inhibition.
    Britton KE; al-Nahhas AM; Nimmon CC; Carroll MJ; Fiore F; Solanki K; Bomanji J
    Contrib Nephrol; 1990; 79():186-9. PubMed ID: 2146083
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects on autonomic function of a new angiotensin converting enzyme inhibitor, ramipril.
    Sugimoto K; Kumagai Y; Tateishi T; Seguchi H; Ebihara A
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S40-4. PubMed ID: 2474100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function.
    Ocón-Pujadas J; Debusmann ER; Jane F; Lahn W; Irmisch R; Mora J; Grötsch H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S45-8. PubMed ID: 2474101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man.
    Böhm RO; van Baak MA; Rahn KH
    Eur J Clin Pharmacol; 1986; 30(5):541-7. PubMed ID: 3019702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of acute administration of ramipril on the excretion of uric acid].
    Labeeuw M; Pozet N; Zech PY; Hadj-Aissa A; Finaz de Villaine J; Laville M
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):870-4. PubMed ID: 2959232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension.
    Lenz T; Distler A; Haller H; Meyer-Sabellek W; Wilp C; Tansey MJ; Eckert HG; Metzger H; Irmisch R; Philipp T
    Arzneimittelforschung; 1986 Nov; 36(11):1693-6. PubMed ID: 3028438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders.
    Todd PA; Benfield P
    Drugs; 1990 Jan; 39(1):110-35. PubMed ID: 2138076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A symposium: Ramipril--a new angiotensin converting enzyme inhibitor. May 2-4, 1986, Brussels, Belgium. Proceedings.
    Am J Cardiol; 1987 Apr; 59(10):1D-177D. PubMed ID: 3034015
    [No Abstract]   [Full Text] [Related]  

  • 10. Short- and long-term effects of ramipril in hypertension.
    de Leeuw PW; Birkenhäger WH
    Am J Cardiol; 1987 Apr; 59(10):79D-82D. PubMed ID: 3034038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of converting enzyme inhibitors on cardiac changes in experimental uremia.
    Rambausek M; Mall G; Kollmar S; Ritz E
    Kidney Int Suppl; 1988 Sep; 25():S201-3. PubMed ID: 2972864
    [No Abstract]   [Full Text] [Related]  

  • 12. Ramipril: review of pharmacology.
    Becker RA; Schölkens B
    Am J Cardiol; 1987 Apr; 59(10):3D-11D. PubMed ID: 3034030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ramipril, a new angiotensin converting enzyme inhibitor, on diurnal variations of blood pressure in essential hypertension.
    Kaneko Y; Omae T; Yoshinaga K; Iimura O; Inagaki Y; Ishii M; Saruta T; Yamada K; Kumahara Y; Ito K
    Am J Cardiol; 1987 Apr; 59(10):86D-91D. PubMed ID: 3034040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril].
    Clauser E
    Rev Prat; 1990 Jun; 40(18 Suppl):10-5. PubMed ID: 2143594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacology of ramipril.
    Omosu M; Komine I; Becker RH; Schölkens BA
    Arzneimittelforschung; 1988 Sep; 38(9):1309-17. PubMed ID: 2975947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, converting enzyme inhibition and peripheral arterial hemodynamics of ramipril in healthy volunteers.
    Thuillez C; Richer C; Giudicelli JF
    Am J Cardiol; 1987 Apr; 59(10):38D-44D. PubMed ID: 3034032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of ramipril diacid on the peripheral vascular effects of angiotensin I.
    Webb DJ; Collier JG
    Am J Cardiol; 1987 Apr; 59(10):45D-49D. PubMed ID: 2953225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of interaction between ramipril, a new ACE-inhibitor, and phenprocoumon, an anticoagulant agent.
    Verho M; Malerczyk V; Grötsch H; Zenbil I
    Pharmatherapeutica; 1989; 5(6):392-9. PubMed ID: 2531901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of the new angiotensin converting enzyme inhibitor ramipril on hemodynamics and carotid sinus baroreflex activity in congestive heart failure.
    Vogt A; Unterberg C; Kreuzer H
    Am J Cardiol; 1987 Apr; 59(10):149D-154D. PubMed ID: 3034024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global and regional hemodynamic effects of ramipril in congestive heart failure.
    Crozier IG; Ikram H; Nicholls MG; Jans S
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):688-93. PubMed ID: 2481181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.